Benoxaprofen-induced photo-onycholysis - 07/10/17
Doi : 10.1016/S0190-9622(82)70151-3
Leah S. McCormack, M.D. ⁎, Mervyn L. Elgart, M.D., Maria L. Turner, M.D.
From the Department of Dermatology, George Washington University Medical Center.
aReprint requests to: Dr. Leah S. McCormack, Department of Dermatology, 2150 Pennsylvania Ave., N.W. Washington, DC 20037.
Résumé |
Benoxaprofen (Opren) is a nonsteroidal anti-inflammatory agent used in the treatment of arthritis. Photosensitivity, including onycholysis, has been reported in the rheumatologic literature. This drug has recently been approved for use in the United States under the name of Oraflex. In order to alert the dermatology community, we report a case of photo-onycholysis which developed in a patient being treated with benoxaprofen and review the data on this drug and its side effects.
Le texte complet de cet article est disponible en PDF.© 1982
Publié par Elsevier Masson SAS.
Vol 7 - N° 5
P. 678-680 - novembre 1982 Retour au numéro
Article précédent
- Heparin necrosis: An anticoagulant-induced cutaneous infarct
- Walter B. Shelley, John J. Saÿen
- Strategies to promote direct access: The public education alternative
- Marcy L. Bohm, John J. Voorhees, John H. Epstein
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?